Log In
Print this Print this

LUNAR-TTR (LUNAR-101) (formerly RNAi therapeutic targeting transthyretin (TTR))

  Manage Alerts
Collapse Summary General Information
Company Arcturus Therapeutics Inc.
DescriptionLUNAR-formulated siRNA targeting the transthyretin (TTR) gene
Molecular Target Transthyretin (TTR)
Mechanism of ActionGene silencing
Therapeutic ModalityNucleic acid: Linear RNA: siRNA
Latest Stage of DevelopmentPreclinical
Standard IndicationAmyloidosis
Indication DetailsTreat familial amyloid cardiomyopathy (FAC); Treat transthyretin (TTR)-mediated amyloidosis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today